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Introduction Patients with newly diagnosed dilated cardiomyopathy and advanced heart failure have a very high morbidity and mortality with an 
unpredictable clinical course. We investigated the role of CMR via LGE (late gadolinium enhancemnt) in this cohort of high-risk patients.
Hypothesis  Utilizing cardiovascular MRI (CMR), via the late gadolinium enhancement (LGE), we assessed the prognostic value in primary dilated 
cardiomyopathy(DCM) patients referred for possible transplantation/LVAD consideration.
Methods Over 39 consecutive months, 51 cardiomyopathy patients were referred for standard 3D CMR(1∙5T,GE) to interrogate the LV pattern, 
distribution and extent of DHE (MultiHance, Princeton, NJ). Inclusion criteria for a pure, non-ischemic, non-identifiable dilated cardiomyopathy 
(DCM) were met in 21 patients and who had EF<45%. DCM were categorized into: 1) +midwall Stripe 2)-Stripe groups. Major adverse clinical events 
(MACE), mortality, need for LV assist device (LVAD), and urgent cardiac transplantation (Tx), were evaluated over the ensuing 6 and 12 months.
Results All patients were alive at 12 months while 11/21 (52%) demonstrated a +Stripe. There were no differences between groups for 
demographics, baseline LVEF, LV end-diastolic diameter, NYHA class or invasive RHC/LHC hemodynamics. The group with +Stripe categorization 
strongly predicted the need for LVAD and/or urgent Tx surgery over the ensuing 6 (or 12) months (p<0.005). Specifically, 7/11(74%) +Stripe 
patients required urgent Tx by 6 months, while no pts in the −Stripe group ever experienced the need for LVAD/urgent Tx (Kaplan-Meier: X2= 
9, p<0.005). Similarly, +Stripe predicted MACE by Cox regression modeling (p<0.05). No pt in the −Stripe group had a MACE at 6 months (one 
rehospitalization at 12 months) or ever crossed over to require LVAD and/or transplantation by 12 months.
Conclusions The presence of +Stripe on CMR is predictive of LVAD and Tx need over the ensuing 6 months and remains robust out to 12 months 
in DCM patients. Incorporating CMR imaging into routine clinical practice may help to identify early those high risk DCM patients; conservatively 
manage low-risk pts while expectantly manage high-risk patients.
